For example, Lee et al. [45] documented that ephrin-A1 (ephrin type-A receptor 1) modified NLCs have also been used to deliver let-7-a into mouse models of non-small cell lung cancer (NSCLC). The gene discussed is EPHA1; the disease is non-small cell lung carcinoma.